Recursion Pharmaceuticals Inc. stocks have been trading down by -4.43 percent after AI drug-discovery partnership concerns ...

From job losses to autonomous weapons, AI poses genuine dangers—but the answer lies in smart oversight, not fear or denial.

Linux commands often have long lists of options they support, many of which are single-letter mnemonics. These can be tricky ...

Leading legal futurist tells IBA Annual Conference that law firms risk missing the bigger picture by focusing on AI-driven productivity gains rather than preparing for a fundamental transformation in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...